share_log

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

Benzinga ·  Apr 30 06:52

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and raises the price target from $3 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment